Understanding the CD28/CTLA-4 (CD152) Pathway and Its Implications for Costimulatory Blockade
Open Access
- 6 August 2014
- journal article
- review article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 14 (9), 1985-1991
- https://doi.org/10.1111/ajt.12834
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell ActivationJournal of Biological Chemistry, 2012
- Selective CD28 Blockade Attenuates Acute and Chronic Rejection of Murine Cardiac Allografts in a CTLA-4-Dependent MannerAmerican Journal of Transplantation, 2011
- B7-H2 Is a Costimulatory Ligand for CD28 in HumanImmunity, 2011
- Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 familyImmunological Reviews, 2011
- CTLA-4 suppresses the pathogenicity of self antigen–specific T cells by cell-intrinsic and cell-extrinsic mechanismsNature Immunology, 2009
- CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic toleranceThe Journal of Experimental Medicine, 2009
- Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturationProceedings of the National Academy of Sciences of the United States of America, 2008
- Induction of autoimmune disease in CTLA-4−/−mice depends on a specific CD28 motif that is required forin vivocostimulationProceedings of the National Academy of Sciences of the United States of America, 2007
- Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell ResponsesImmunity, 2007
- Cytotoxic T lymphocyte antigen‐4‐dependent down‐modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T‐cell‐mediated suppressionImmunology, 2006